We compared the efficacy and safety of an extrafine combination inhaler containing a corticosteroid ( beclometasone ) plus a rapid-onset , long-acting 2 agonist ( formoterol ) with a short-acting 2 agonist ( salbutamol ) as reliever strategies in patients taking beclometasone-formoterol combination as maintenance treatment .